Home > Healthcare > Medical Devices > Medical Supplies > Cannula Market

Cannula Market Trends

Report ID: GMI4525
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Cannula Market Trends

The growing burden of chronic disease is anticipated to stimulate market value. Chronic diseases often require long-term management and treatment, which may involve the use of medical devices including cannulas. Conditions such as diabetes, cardiovascular diseases, respiratory disorders, and certain types of cancer may require regular administration of medications, fluids, or other therapies using cannulas. For instance, in 2022, as per estimates, about 80% of the elderly population base have at least one chronic condition, and approximately 60% have around two chronic conditions. Furthermore, increasing number of infections led to higher adoption rate of infection control supplies including cannula.

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Global market for cannula was valued over USD 162 million in 2022 and will reach USD 335 million by 2032 as cannulas are commonly used in medical procedures to deliver or remove fluids, gases, or medications to or from different parts of the body.

The cardiac segment is estimated to account for USD 152.8 million by 2032 as the product provides access to the heart chambers and major blood vessels, allowing for various interventions.

U.S. industry accounted for USD 61.3 million in 2022 and will reach USD 124.5 million by 2032, owing to the affordability of medical procedures among the target population base and ongoing technological developments.

include Medtronic, Becton Dickinson (BD), Edward Lifesciences, LivaNova, Smiths Medical, Boston Scientific Corporation, Terumo Corporation, Fisher & Paykel Healthcare Ltd. among others.